Found 41 matching trials
Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients
NAThe purpose of this study is to investigate if co-treatment of acromegalic ...
Location
Department of Endocrinology, Aarhus University Hospital
Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan
N/AThe objective of this surveillance is to collect information about 1) adver...
Location
Multiple Locations
Strict IGF-1 Control in Acromegaly
PHASE3Acromegaly is a rare, chronic, and debilitating disease, usually caused by ...
Location
University of Alberta Hospital
Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During Fasting
NABackground: Calorie restriction increases longevity in many species and att...
Location
Aarhus University Hospital
Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients
PHASE3The main aim of this study is to assess the efficacy of the co-administrati...
Location
University Hospital, Charles University
Non Interventional Study For Patients Treated With Somavert®
N/AThis open-label, national, prospective, observational, non-interventional, ...
Location
Multiple Locations
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
PHASE4This study will investigate the efficacy of a combination treatment with oc...
Location
Novartis Investigative Site
Long Term Study With B2036-PEG
PHASE3Primary objective: To investigate the efficacy and safety of Pegvisomant in...
Location
Pfizer Investigational Site
Effect of DPP4 Inhibition on Growth Hormone Secretion
PHASE4This study tests the following hypotheses:
Aim 1: Test the hypothesis that...
Location
Vanderbilt University Medical Center
Growth Hormone Signaling in Vivo in Humans
NAObjective: GH induces insulin resistance in muscle and fat and in vitro dat...
Location
Medical Research Laboratories